Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia

BACKGROUND: Treatment of patients with chronic myeloid leukaemia (CML) has become increasingly difficult in recent years due to the variety of treatment options available and challenge deciding on the most appropriate treatment strategy for an individual patient. To facilitate the treatment strategy...

Descripción completa

Detalles Bibliográficos
Autores principales: Banjar, Haneen, Ranasinghe, Damith, Brown, Fred, Adelson, David, Kroger, Trent, Leclercq, Tamara, White, Deborah, Hughes, Timothy, Chaudhri, Naeem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207707/
https://www.ncbi.nlm.nih.gov/pubmed/28045960
http://dx.doi.org/10.1371/journal.pone.0168947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207707/
https://www.ncbi.nlm.nih.gov/pubmed/28045960
http://dx.doi.org/10.1371/journal.pone.0168947

Ejemplares similares